Cognition
Huperzine-A
Acetylcholinesterase inhibitor from Chinese club moss that may improve cognitive symptoms in dementia; evidence in healthy adults is limited.
Huperzine-A
Acetylcholinesterase inhibitor from Chinese club moss that may improve cognitive symptoms in dementia; evidence in healthy adults is limited.
46
C
evidenceCaution
riskProven Benefits
01Improves cognition in dementia
02May improve memory in adults
03May support neuroprotection
Chemical Forms
Recommended
- Huperzine-A (pure alkaloid)
- Huperzia serrata extract (standardized)
Avoid
- Generic Huperzia serrata powder (unknown alkaloid content)
Expert Note
Effective dosing depends on the huperzine-A alkaloid, typically 200 mcg. Non-standardized plant powders contain variable and often subtherapeutic levels of the active compound.
Protocol
Amount
200-400 mcg
Frequency
Once or twice daily
When
Morning and/or afternoon; avoid late evening due to potential insomnia from cholinergic stimulation.
Condition-Based Dosing
Alzheimer's disease or vascular dementia
200-400 mcg daily in divided doses
General cognitive support in healthy adults
200 mcg daily
Safety & Limits
Upper Safe Limit
400 mcg/day (highest studied chronic dose; no official UL established)
Cycling
Safe for continuous use
Contraindications
Bradycardia, heart block, or seizure disorders — cholinergic excess can worsen these
Pregnancy and breastfeeding — insufficient safety data
Concurrent use of donepezil, rivastigmine, or other AChE inhibitors — risk of cholinergic crisis
Asthma or COPD — may increase bronchial secretions and bronchoconstriction
Gastrointestinal ulcer disease — increased gastric acid may worsen ulcers
Synergies
Choline donors provide substrate for acetylcholine synthesis, potentially complementing acetylcholinesterase inhibition.
Avoid Combining With
- ✕Anticholinergic medications (counteract effects)
- ✕Acetylcholinesterase inhibitors like donepezil or rivastigmine (risk of cholinergic crisis — do not combine)
Updated Invalid Date